Clonal Heterogeneity in Patients with Myelodysplastic Syndromes (MDS) and Complex Karyotypes

被引：0
|
作者：
Zemanova, Zuzana [1 ,2 ]
Michalova, Kyra [1 ,2 ]
Brezinova, Jana [3 ]
Lhotska, Halka [1 ,2 ]
Svobodova, Karla [1 ,2 ]
Sarova, Iveta [3 ]
Lizcova, Libuse [1 ,2 ]
Izakova, Silvia [1 ,2 ]
Ransdorfova, Sarka [3 ]
Krejcik, Zdenek [3 ]
Belickova, Monika [3 ]
Siskova, Magda [1 ,2 ]
Jonasova, Anna [4 ]
Neuwirtova, Radana [2 ,5 ]
Zmolikova, Jana [6 ]
Cermak, Jaroslav [3 ]
机构：
[1] Charles Univ Prague, Gen Univ Hosp, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 1, Prague, Czech Republic
[3] Inst Hematol & Blood Transfus, CR-12820 Prague, Czech Republic
[4] Charles Univ Prague, Dept Med 1, Gen Hosp, Prague, Czech Republic
[5] Charles Univ Prague, Gen Univ Hosp, Dept Med 1, Prague, Czech Republic
[6] CGB Lab, Ostrava, Czech Republic
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Phase II study of amifostine in patients with myelodysplastic syndromes (MDS).
    List, AF
    Holmes, H
    Greenberg, PL
    Bennett, JM
    Oster, W
    BLOOD, 1999, 94 (10) : 305A - 305A
  • [42] Clinical Experience of Decitabine in Elderly Patients with Myelodysplastic Syndromes (MDS)
    Geils, George F., Jr.
    BLOOD, 2009, 114 (22) : 1092 - 1092
  • [43] Characteristics and Outcome Of Myelodysplastic Syndromes (MDS) Patients With Autoimmune Diseases
    Komrokji, Rami S.
    Kulasekararaj, Austin G.
    Al Ali, Najla H.
    Kordasti, Shahram Y.
    Bart-smith, Emily
    Benjamin, Craig
    Padron, Eric
    Zhang, Ling
    Lancet, Jeffrey E.
    List, Alan
    Mufti, Ghulam J.
    Epling-Burnette, Pearlie K.
    BLOOD, 2013, 122 (21)
  • [44] CLASSIFICATION AND TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS)
    CATOVSKY, D
    MYELODYSPLASTIC SYNDROMES : PATHOPHYSIOLOGY AND TREATMENT, 1988, 783 : 3 - 3
  • [45] MYELODYSPLASTIC SYNDROMES (MDS) IN CENTRAL AFRICANS
    MUKIIBI, JM
    PAUL, B
    TROPICAL AND GEOGRAPHICAL MEDICINE, 1994, 46 (01): : 17 - 19
  • [46] BALLOONING PLATELETS IN THE MYELODYSPLASTIC SYNDROMES (MDS)
    JAKOBSEN, PEO
    HANSEN, JB
    PEDERSEN, JO
    JENSEN, MK
    NIELSEN, LC
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1994, 53 (03) : 175 - 177
  • [47] GRANULOCYTIC SARCOMAS IN MYELODYSPLASTIC SYNDROMES (MDS)
    DASILVA, MAP
    MORIARTY, A
    TRICOT, GJ
    BLUT, 1988, 56 (06): : C7 - C7
  • [48] IMMUNOTHERAPY STRATEGIES IN MYELODYSPLASTIC SYNDROMES (MDS)
    Gill, Saar
    LEUKEMIA RESEARCH, 2021, 108 : S57 - S57
  • [49] BMT in children with myelodysplastic syndromes (MDS).
    Kardos, G
    Vossen, JMJJ
    Hoogerbrugge, PM
    BLOOD, 1997, 90 (10) : 373 - 373
  • [50] PROGNOSTIC FACTORS IN MYELODYSPLASTIC SYNDROMES (MDS)
    TRICOT, G
    VLIETINCK, R
    HENDRICKX, B
    VERWILGHEN, RL
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 60 (02) : 362 - 362
12345